Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An update on the complex relationship between clozapine and pneumonia
Georgios Schoretsanitis, Can‐Jun Ruan, Christopher Rohde, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 2, pp. 145-149
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
José de León, Georgios Schoretsanitis, Robert L. Smith, et al.
Pharmacopsychiatry (2021) Vol. 55, Iss. 02, pp. 73-86
Open Access | Times Cited: 178
Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia
Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, et al.
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108236-108236
Open Access | Times Cited: 48
A population pharmacokinetic model to guide clozapine dose selection, based on age, sex, ethnicity, body weight and smoking status
Suzanne Reeves, Julie Bertrand, Stephen John Obee, et al.
British Journal of Clinical Pharmacology (2023) Vol. 90, Iss. 1, pp. 135-145
Open Access | Times Cited: 31
Reflections on the Lack of Consideration of Ethnic Ancestry to Stratify Clozapine Dosing
José de León
Psychiatry Investigation (2023) Vol. 20, Iss. 3, pp. 183-195
Open Access | Times Cited: 22
The Modernization of Clozapine
Jonathan G. Leung, José de León, Mark A. Frye, et al.
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 6, pp. 565-580
Closed Access | Times Cited: 30
An international guideline with six personalised titration schedules for preventing myocarditis and pneumonia associated with clozapine
José de León, Can‐Jun Ruan, Georgios Schoretsanitis, et al.
General Psychiatry (2022) Vol. 35, Iss. 3, pp. e100773-e100773
Open Access | Times Cited: 29
Escaping the Long Shadow Cast by Agranulocytosis
José de León, Manuel Arrojo, Hélène Verdoux, et al.
Journal of Clinical Psychopharmacology (2023) Vol. 43, Iss. 3, pp. 239-245
Closed Access | Times Cited: 19
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Mishal Qubad, Robert A. Bittner
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 17
Risks and benefits of clozapine and lithium co-prescribing: A systematic review and expert recommendations
Hélène Verdoux, Clélia Quilès, José de León
Schizophrenia Research (2023) Vol. 268, pp. 233-242
Closed Access | Times Cited: 16
Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases
Renato de Filippis, John M. Kane, Nazar Kuzo, et al.
European Neuropsychopharmacology (2022) Vol. 60, pp. 25-37
Open Access | Times Cited: 23
Clozapine for persons with neurodevelopmental disorders: a systematic review and expert recommendations for clinical practice
Hélène Verdoux, Clélia Quilès, José de León
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 10, pp. 923-933
Closed Access | Times Cited: 4
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Schizophrenia and Related Psychoses

(2025), pp. 1-278
Closed Access
Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital
Nuree Kang, Se Hyun Kim, Jayoun Kim, et al.
Schizophrenia Research (2023) Vol. 268, pp. 107-113
Closed Access | Times Cited: 11
High Burden of Ileus and Pneumonia in Clozapine-Treated Individuals With Schizophrenia: A Finnish 25-Year Follow-Up Register Study
Juulia Partanen, Paavo Häppölä, Anders Kämpe, et al.
American Journal of Psychiatry (2024)
Closed Access | Times Cited: 4
Respiratory aspiration during treatment with clozapine and other antipsychotics: a literature search and a pharmacovigilance study in vigibase
Carlos De las Cuevas, Emílio J. Sanz, Alejandro Villasante‐Tezanos, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 2, pp. 57-74
Open Access | Times Cited: 10
Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK
Carlos De las Cuevas, Emílio J. Sanz, Jason A. Gross, et al.
Schizophrenia Research (2023) Vol. 268, pp. 175-188
Open Access | Times Cited: 10
An efficient CoFe2O4@SiO2@APTES@ATA@CuCl2 magnetic nanocatalyst: A suitable platform for the synthesis of polycyclic fused 1,5-benzodiazepines via domino reactions
Fan Bai, Nian Liu, Huihui Ru, et al.
Polyhedron (2024) Vol. 260, pp. 117094-117094
Closed Access | Times Cited: 3
Investigating in VigiBase® over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia
José de León, Can‐Jun Ruan, Georgios Schoretsanitis, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 8, pp. 857-871
Closed Access | Times Cited: 3
The history of clozapine in clinical practice: From its introduction to a guideline proposing personalized titrations
José de León
Journal of Psychopharmacology (2022) Vol. 36, Iss. 6, pp. 657-660
Closed Access | Times Cited: 13
Successful rechallenge with clozapine after discontinuation due to drug‐induced pneumonia: A case report
Yuki Kikuchi, Hiroshi Komatsu, Atsushi Sakuma, et al.
Psychiatry and Clinical Neurosciences Reports (2022) Vol. 1, Iss. 3
Open Access | Times Cited: 10
Clozapine-Associated Agranulocytosis
Carlo Magistri, Cristiano Mellini
Journal of Clinical Psychopharmacology (2023) Vol. 43, Iss. 6, pp. 527-533
Closed Access | Times Cited: 5
Prevalence of clozapine-induced sialorrhea and its effect on quality of life
David Sanagustín, Marta Martín-Subero, Bridget Hogg, et al.
Psychopharmacology (2022) Vol. 240, Iss. 1, pp. 203-211
Closed Access | Times Cited: 8
Clozapine—serious adverse effects and clinical management
Vlad Dionisie
Elsevier eBooks (2024), pp. 329-355
Closed Access | Times Cited: 1
Recurrent Clozapine-Associated Pneumonia
Carolanne Wartman, Melodie Vick, Bethany Thomas
Journal of Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top